Brossard, Quebec – TheNewswire - le 20 octobre 2025 – CORPORATION CHARBONE (TSXV: CH; OTCQB: CHHYF; FSE: K47) (« CHARBONE » ou la « Société »), un producteur et distributeur nord-américain spécialisé dans l'hydrogène propre à Ultra Haute Pureté (« UHP ») et les gaz industriels stratégiques, a le plaisir d'annoncer la conclusion d'une alliance stratégique et de multiples ententes d'approvisionnement commercial avec un important producteur et distributeur américain de gaz industriels dont le siège social est ...

Core Insights - CHARBONE CORPORATION has formed a strategic alliance and multiple commercial supply agreements with a major U.S. industrial gas producer, enhancing its position in the North American market for low-carbon and ultra-high-purity gases [1][2][3] Company Developments - The alliance allows CHARBONE to expand its product offerings by adding high-value gases, particularly helium, which will strengthen its operational flexibility and logistics [2][3] - This partnership is a significant milestone in CHARBONE's long-term growth strategy, aimed at diversifying revenue streams and consolidating its presence in the Canadian market [3][5] - The collaboration is expected to meet the increasing demand from various industrial sectors, including gas distributors, semiconductor, data-center, energy, petrochemical, and refining industries [3] Market Outlook - The global industrial gas market is projected to grow by USD 31.1 billion from 2024 to 2029, with an average annual growth rate of 5.7% [4] - This growth presents opportunities for CHARBONE to enhance its market share and contribute to the resilience of North America's specialty gas supply chain [3][5] Strategic Positioning - CHARBONE's approach involves building a distributed network of green hydrogen production plants while diversifying revenues through helium and specialty gas partnerships [6] - The company aims to minimize risk and maximize opportunities by collaborating with world-class partners, reinforcing its leadership in hydrogen and expanding into new markets [5][6]

Core Insights - NextEra Energy has received a 20-year license renewal for its Point Beach Nuclear Plant, allowing operations through 2050 and 2053, which supports its energy initiatives [1] - NextEra Energy is a leading electric utility holding company focused on scaling electricity and expanding resources to meet increasing U.S. energy demand [2] - The company reported a 10.4% year-over-year sales increase to $6.7 billion and a 25% rise in net income to $2.03 billion in its most recent quarter [6] Financial Performance - NextEra's stock is trading at $85.05 with a forward annual dividend of $2.27, yielding approximately 2.7% and a dividend payout ratio of 59.95% [6] - Lowe's Companies reported a 1.6% year-over-year sales increase to $23.96 billion and a net income rise of 0.6% to $2.4 billion, with stock trading at $243.10 and a forward annual dividend of $4.80, yielding just under 2% [10] - Atmos Energy reported a 19.6% sales increase to $838.8 million and a net income rise of 12.6% to $186.4 million, with stock trading at $176.37 and a forward annual dividend of $3.48, yielding approximately 2% [14] - Abbott Laboratories saw a 7.4% sales increase to $11.14 billion and a 36.6% rise in net income to $1.78 billion, with stock trading at $127.63 and a forward annual dividend of $2.36, yielding approximately 1.8% [19] - Linde Plc reported a 2.8% sales increase to $8.5 billion and a 6.2% rise in net income to $1.77 billion, with stock trading at $444.24 and a forward annual dividend of $6.00, yielding approximately 1.4% [23] Analyst Ratings - NextEra Energy has a consensus rating of "Moderate Buy" with a score of 4.05/5 from 21 analysts, reflecting increased sentiment over the last three months [7] - Lowe's Companies has a consensus rating of "Moderate Buy" with a score of 4.21/5 from 29 analysts, showing a slight decrease in sentiment [11] - Atmos Energy has a consensus rating of "Moderate Buy" with a score of 3.64/5 from 14 analysts, with consistent but slightly declining sentiment [15] - Abbott Laboratories has a consensus rating of "Strong Buy" with a score of 4.45/5 from 29 analysts, strengthening from a "Moderate Buy" three months ago [20] - Linde Plc has a consensus rating of "Strong Buy" with a score of 4.41/5 from 27 analysts, with no analysts holding a "sell" rating [24]

Core Insights - Goldman Sachs has added four new stocks to its Conviction List, which are expected to have double-digit upside potential and three of which offer reliable dividends [4][5][6]. Group 1: Goldman Sachs Conviction List - The Conviction List is a curated selection of stocks that Goldman Sachs analysts believe will outperform the market, focusing on themes like artificial intelligence and sustainability [2][4]. - The four new stocks added in October are Abbott Laboratories, Air Products and Chemicals, Hershey, and Madison Square Garden Entertainment [5][6]. Group 2: Stock Details - **Abbott Laboratories**: Offers a 1.74% dividend with a target price of $157, indicating a potential 17% gain [7][8]. - **Air Products and Chemicals**: Provides a 2.63% dividend and has a target price of $335, suggesting a 23% upside [9][15]. - **Hershey**: Features a 2.82% dividend with a target price of $222, representing a potential 19% gain [16][20]. - **Madison Square Garden Entertainment**: A live entertainment company with a target price of $52, indicating a 15% upside [21][23].

Core Insights - Linde plc, with a market cap of $214.1 billion, is a leading global industrial gases and engineering company serving various industries including healthcare, chemical, energy, manufacturing, and electronics [1] Financial Performance - Linde is expected to announce fiscal Q3 2025 results on October 31, with analysts predicting an adjusted EPS of $4.18, reflecting a 6.1% increase from $3.94 in the same quarter last year [2] - For fiscal 2025, analysts forecast an adjusted EPS of $16.46, a 6.1% growth from $15.51 in fiscal 2024, and a further increase to $17.97 in fiscal 2026, representing a 9.2% year-over-year growth [3] Stock Performance - Over the past 52 weeks, Linde's shares have declined nearly 5%, underperforming the S&P 500 Index's 14.4% return, but faring better than the Materials Select Sector SPDR Fund's 9.4% decrease [4] - Despite reporting better-than-expected Q2 2025 adjusted EPS of $4.09 and revenues of $8.5 billion, Linde's shares fell slightly due to a disappointing operating profit in the Engineering segment and lower volumes in key markets [5] Analyst Ratings - The consensus among analysts is bullish, with a "Strong Buy" rating for Linde stock; 18 out of 27 analysts recommend a "Strong Buy," 2 suggest a "Moderate Buy," and 7 recommend a "Hold" [6] - The average analyst price target for Linde is $518.30, indicating a potential upside of 13.5% from current levels [6]

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Air Products and Chemicals Inc. (NYSE:APD) is a global leader in providing industrial gases, related equipment, and applications expertise to industries like refining, chemical, metals, electronics, and food and beverage. It will report its Q4 2025 earnings on Nov. 6. Wall Street analysts expect the company to post EPS of $3.40, down from $3.56 in the prior-year period. According to data from Benzinga Pro, ...

Core Viewpoint - Air Products is set to hold a conference call on November 6, 2025, to discuss its fiscal 2025 fourth quarter financial results, which will be accessible to the public and media in listen-only mode [1]. Company Overview - Air Products (NYSE: APD) is a leading industrial gases company with over 80 years of operation, focusing on energy, environmental, and emerging markets to promote a cleaner future [3]. - The company supplies essential industrial gases and related equipment to various industries, including refining, chemicals, metals, electronics, manufacturing, medical, and food [3]. - As the top global supplier of hydrogen, Air Products is involved in developing and operating some of the largest clean hydrogen projects, aiding the transition to low- and zero-carbon energy [3]. Financial Performance - In fiscal 2024, Air Products reported sales of $12.1 billion from operations across approximately 50 countries [4]. - The company currently has a market capitalization of about $60 billion [4].

Market Overview - Stocks were higher on Wednesday, with both the S&P 500 and Nasdaq on track for record closes, following a rebound in AI infrastructure and technology stocks [1] - Nvidia shares increased nearly 2% in Wednesday afternoon trading [1] Company Insights - Linde's shares are up about 12% this year, despite a slow start in October due to macroeconomic concerns [1] - Goldman Sachs remains favorable on Linde, expecting third-quarter results toward the high end of its guidance range, which is $4.10 to $4.20 per share, indicating year-over-year growth of 4% to 7% [1] - BNP Paribas noted that Linde's CFO's commentary aligns with previous assumptions, with potential for more favorable currency conditions [1] - Linde is recognized for consistently beating earnings estimates and outperforming peers due to its pricing power and cost management [1] Industry Developments - Amazon Pharmacy plans to launch in-office kiosks in One Medical locations starting December 2025, aiming to enhance healthcare access [1] - The kiosks will offer common medications and are tailored to specific prescribing patterns, posing a threat to CVS's core pharmacy business [1] - Amazon's healthcare ambitions could disrupt the sector, leveraging its existing services for Prime Members [1] - Amazon's stock performance has been disappointing in 2025 compared to its peers, with a need for Amazon Web Services to show revenue growth re-acceleration [1] Upcoming Earnings - PepsiCo and Delta Airlines are scheduled to report earnings before the opening bell on Thursday [1]

Core Insights - Non-U.S. companies are planning to expand or establish operations in the United States to counteract the effects of President Trump's tariffs on imported goods Company Investments - Air Liquide plans to invest up to $200 million in Louisiana and over $50 million in the U.S. semiconductor industry [2] - AstraZeneca intends to spend $50 billion on a new plant in Virginia and expansions in several states including Maryland, Massachusetts, California, Indiana, and Texas [3] - Honda aims to shift some car production from Mexico and Canada to the U.S., targeting 90% local production for cars sold in the country [4] - Hyundai Motor is localizing production in the U.S. and will manufacture hybrid vehicles at a new factory in Georgia [5] - Inventec has agreed to invest up to $85 million to build manufacturing facilities in Texas [6] - Lavazza plans to increase its U.S. production from 50% to 100% of its sales [7] - Nissan is considering moving production of its Sentra automobile from Mexico to the U.S. and shifting some domestic production of U.S.-bound vehicles [8] - Novartis plans to invest $23 billion to build and expand 10 facilities in the U.S. [9] - Roche will invest $50 billion in the U.S. over the next five years and announced an additional $550 million for its Indianapolis diagnostics manufacturing hub [10] - Rolls-Royce plans a $75 million investment to enhance U.S. manufacturing capabilities in South Carolina [11] - Samsung Electronics is considering relocating dryer manufacturing from Mexico to its South Carolina plant [13] - Sanofi plans to invest at least $20 billion in the U.S. through 2030 to enhance manufacturing and research [14] - Stellantis is set to invest about $10 billion in the United States [15]

Core Insights - Understanding the performance of leading European stocks reveals differences compared to American firms, with Europe excelling in fashion and having notable successes in tech and defense [4][8] - Long-term value creation is essential for sustained performance, with firms that consistently excel in customer value, autonomous networks, and adaptive mindsets outperforming others [4][8] Consistently Poor Performers - Diageo PLC: Overall score 8.2/15.0, TSR/S&P500 at 7%/243% [5] - Bayer: Overall score 8.2/15.0, TSR/S&P500 at 20%/243% [5] - Sanofi S.A.: Overall score 8.5/15.0, TSR/S&P500 at 50%/243% [5] - National Grid: Overall score 8.8/15.0, TSR/S&P500 at 67%/243% [5] - Adidas: Overall score 8.5/15.0, TSR/S&P500 at 173%/243% [5] - Anheuser-Busch InBev: Overall score 8.7/15.0, TSR/S&P500 at 50%/243% [5] Mixed Performers - Nestlé S.A.: Overall score 8.9/15.0, TSR/S&P500 at 55%/243% [6] - British American Tobacco: Overall score 8.9/15.0, TSR/S&P500 at 74%/243% [6] - Unilever PLC: Overall score 8.5/15.0, TSR/S&P500 at 94%/243% [6] - Allianz: Overall score 9.3/15.0, TSR/S&P500 at 133%/243% [6] - L'Oréal: Overall score 10.2/15.0, TSR/S&P500 at 168%/243% [6] - HSBC Holdings: Overall score 8.7/15.0, TSR/S&P500 at 203%/243% [6] Consistently Successful Firms - EssilorLuxottica: Overall score 10.5/15.0, TSR/S&P500 at 204%/243% [7] - AXA: Overall score 9.0/15.0, TSR/S&P500 at 218%/243% [7] - Novo Nordisk: Overall score 11.2/15.0, TSR/S&P500 at 103%/243% [7] - Enel: Overall score 9.0/15.0, TSR/S&P500 at 246%/243% [7] - LVMH: Overall score 10.8/15.0, TSR/S&P500 at 291%/243% [7] - Relx: Overall score 9.8/15.0, TSR/S&P500 at 296%/243% [7] - AstraZeneca: Overall score 10.0/15.0, TSR/S&P500 at 300%/243% [7] High Performers - Iberdrola: Overall score 9.2/15.0, TSR/S&P500 at 307%/243% [9] - Siemens: Overall score 10.2/15.0, TSR/S&P500 at 309%/243% [9] - Airbus: Overall score 10.2/15.0, TSR/S&P500 at 312%/243% [9] - SAP: Overall score 11.0/15.0, TSR/S&P500 at 357%/243% [9] - Zurich Insurance Group: Overall score 9.2/15.0, TSR/S&P500 at 370%/243% [9] - Münchener Rück: Overall score 9.4/15.0, TSR/S&P500 at 402%/243% [9] - Linde PLC: Overall score 10.0/15.0, TSR/S&P500 at 424%/243% [9] - ABB: Overall score 10.2/15.0, TSR/S&P500 at 444%/243% [9] - Schneider Electric: Overall score 10.5/15.0, TSR/S&P500 at 486%/243% [9] - Hermes: Overall score 11.0/15.0, TSR/S&P500 at 546%/243% [9] - Rheinmetall: Overall score 9.5/15.0, TSR/S&P500 at +1000%/243% [9] - ASML: Overall score 11.5/15.0, TSR/S&P500 at 1070%/243% [9]